MedTrace Logo

Incidence of Diabetes After a COVID-19 Infection

NCT05524792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 157134

Last updated 2024-03-25

No results posted yet for this study

Summary

Prospective observational study of the POINTED consortium to evaluate whether new diagnoses of diabetes mellitus, occur significantly more frequently in the post-acute phase of a laboratory-confirmed SARS-CoV-2 infection than in carefully matched control groups.

Conditions

Interventions

OTHER

no interventional study

no interventional study

Sponsors & Collaborators

  • Robert Koch Institut

    collaborator OTHER_GOV

  • Center for Evidence-Based Healthcare, Technische Universität Dresden

    collaborator UNKNOWN

  • Techniker Krankenkasse

    collaborator OTHER

  • BARMER

    collaborator OTHER

  • DAK Gesundheit

    collaborator OTHER

  • AOK PLUS

    collaborator INDUSTRY

  • Vandage GmbH

    collaborator UNKNOWN

  • IKK Classic

    collaborator UNKNOWN

  • InGef - Institute for Applied Health Research Berlin GmbH

    lead INDUSTRY

Principal Investigators

  • Jochen Schmitt, Prof. Dr. med. · Center for Evidence-Based Healthcare, Technische Universität Dresden

  • Josephine Jacob, MSc · InGef - Institute for Applied Health Research Berlin GmbH

  • Christa Scheidt-Nave, Dr. · Robert Koch-Institut; Fachgebiet 25 - Körperliche Gesundheit

  • Lukas Reitzle, Dr. · Robert Koch-Institut; Fachgebiet 24: Gesundheits-bericht-erstattung

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05524792 on ClinicalTrials.gov